Product
Treatment Choice
1 clinical trial
1 indication
Indication
Acute Myeloid LeukemiaClinical trial
A Phase 3, Multicenter, Randomized, Open-Label Study of Guadecitabine (SGI-110) Versus Treatment Choice in Adults With Previously Treated Acute Myeloid LeukemiaStatus: Completed, Estimated PCD: 2020-01-20